Contoso Pharmaceuticals Presentation Cover Option 1 Lorem ipsum

  • Slides: 23
Download presentation
Contoso Pharmaceuticals Presentation Cover Option 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Contoso Pharmaceuticals Presentation Cover Option 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Presentation Cover Option 2 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Contoso Pharmaceuticals

Presentation Cover Option 2 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Contoso Pharmaceuticals page 2

 • Lorem ipsum dolor sit amet, consectetur adipiscing elit. • Ut fermentum a

• Lorem ipsum dolor sit amet, consectetur adipiscing elit. • Ut fermentum a magna ut eleifend. Integer convallis suscipit ante eu varius. • Morbi a purus dolor. Suspendisse sit amet ipsum finibus justo viverra blandit. • Ut congue quis tortor eget sodales. About Us Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut. Contoso Pharmaceuticals page 3

The Problem Declining Market Financial Trust Cost Margins Lorem ipsum dolor sit amet, consectetur

The Problem Declining Market Financial Trust Cost Margins Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut eleifend. Integer convallis suscipit ante eu varius. Morbi a purus dolor. Suspendisse sit amet ipsum varius finibus justo viverra blandit. Ut congue quis tortor varius eget sodales. Contoso Pharmaceuticals page 4

Prioritize Authorize Monetize Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu

Prioritize Authorize Monetize Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi quis lacinia. Integer convallis suscipit ante eu varius. Solution Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi quis. Contoso Pharmaceuticals page 5

Unique First to Market Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet

Unique First to Market Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi. Ut fermentum a magna ut eleifend. Product Tested Authentic Integer convallis suscipit eu varius. Morbi a purus dolor. Suspendisse sit amet ipsum varius finibus justo viverra blandit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi quis. Contoso Pharmaceuticals page 6

Emphasize your main benefit Other benefits include • Lorem ipsum dolor sit amet, consectetur

Emphasize your main benefit Other benefits include • Lorem ipsum dolor sit amet, consectetur adipiscing elit. • Nunc tempus, risus sodales hendrerit, arcu dolor commodo libero. Contoso Pharmaceuticals page 7

Section Divider Lorem ipsum dolor sit amet, consectetur adipiscing elit Contoso Pharmaceuticals page 8

Section Divider Lorem ipsum dolor sit amet, consectetur adipiscing elit Contoso Pharmaceuticals page 8

Business Model Lorem ipsum dolor sit amet, consectetur adipiscing elit. Research Finance Invest Lorem

Business Model Lorem ipsum dolor sit amet, consectetur adipiscing elit. Research Finance Invest Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut eleifend. Integer convallis suscipit ante eu varius. Morbi a purus dolor. Contoso Pharmaceuticals page 9

Market Opportunity Option 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit. $1 B

Market Opportunity Option 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit. $1 B $2 B • Lorem ipsum dolor sit amet, consectetur adipiscing elit. • Ut congue quis tortor eget sodales. Nulla a erat eget nunc hendrerit ultrices eu nec nulla. • Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut eleifend. Integer convallis suscipit ante eu varius. • Morbi a purus dolor. Suspendisse sit amet ipsum finibus justo viverra blandit. • Donec viverra leo aliquet, auctor quam id, convallis orci. Contoso Pharmaceuticals page 10

Market Opportunity Option 2 Integer convallis suscipit ante eu varius. Morbi a purus dolor.

Market Opportunity Option 2 Integer convallis suscipit ante eu varius. Morbi a purus dolor. $3 B $2 B $1 B Opportunity to Build Freedom to Invent Few Competitors Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut eleifend. Integer convallis suscipit ante eu varius. Morbi a purus dolor. Contoso Pharmaceuticals page 11

Competition Option 1 Contoso Pharmaceuticals • Nulla a erat eget nunc hendrerit ultrices eu

Competition Option 1 Contoso Pharmaceuticals • Nulla a erat eget nunc hendrerit ultrices eu nec nulla. Donec viverra leo aliquet, auctor quam id, convallis orci. • Sed in molestie est. Cras ornare turpis at ligula posuere, sit amet accumsan neque lobortis. • Maecenas mattis risus ligula, sed ullamcorper nunc efficitur sed. Competitor Praesent venenatis quam tortor, id viverra nunc rutrum a. Maecenas malesuada ultricies sapien sit amet pharetra. Nunc tempus, risus sodales hendrerit, arcu dolor commodo libero, a sollicitudin quam nulla quis lectus. In at porta mauris. Contoso Pharmaceuticals page 12

Competition Option 2 Convenience Contoso Pharmaceuticals Expensive Affordable Inconvenient Contoso Pharmaceuticals page 13

Competition Option 2 Convenience Contoso Pharmaceuticals Expensive Affordable Inconvenient Contoso Pharmaceuticals page 13

Growth Strategy How will we scale in the future Phase 1 Month, Year •

Growth Strategy How will we scale in the future Phase 1 Month, Year • Lorem ipsum dolor sit amet, consectetur adipiscing elit. • Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut eleifend. Integer convallis suscipit ante eu varius. Phase 2 Month, Year • Morbi a purus dolor. Suspendisse sit amet ipsum finibus justo viverra blandit. • Ut congue quis tortor eget sodales. Nulla a erat eget nunc hendrerit ultrices eu nec nulla. Phase 3 Month, Year • Donec viverra leo aliquet, auctor quam id, convallis orci. • Lorem ipsum dolor sit amet, consectetur adipiscing elit. Contoso Pharmaceuticals page 14

Traction Forecasting for success Vendors Users Gross Revenue Company Revenue Gross Revenue $300, 000

Traction Forecasting for success Vendors Users Gross Revenue Company Revenue Gross Revenue $300, 000 20 YY 0 0 $0 $0 $250, 000 20 YY 10 100 $6, 750 $1, 013 $200, 000 $150, 000 20 YY 50 500 $33, 750 $5, 063 $100, 000 20 YY 2000 $135, 000 $20, 250 20 YY 4000 $270, 000 $40, 500 $50, 000 $0 1 2 3 4 5 Contoso Pharmaceuticals page 15

Timeline Our two-year action plan AUG Trials Marketing Launch Month, 20 YY SEP OCT

Timeline Our two-year action plan AUG Trials Marketing Launch Month, 20 YY SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP 20 YY OCT NOV DEC JAN FEB MAR APR MAY 20 YY Legislation Investment Procurement Month, 20 YY Contoso Pharmaceuticals page 16

Financials Year 1 Year 2 Year 3 5, 000 40, 000 160, 000 Users

Financials Year 1 Year 2 Year 3 5, 000 40, 000 160, 000 Users 50, 000 400, 000 1 600, 000 Sales 500, 000 4 000, 000 16 000, 000 75 80 90 5 625, 000 48 000, 000 216 000, 000 • Sales & Marketing 5 062, 500 38 400, 000 151 200, 000 70% • Customer Service 1 687, 500 9 600, 000 21 600, 000 10% • Product Development 562, 500 2 400, 000 10 800, 000 5% • Research 281, 250 2 400, 000 4 320, 000 2% 7 593, 750 52 800, 000 187 920, 000 -1 968, 750 -4 800, 000 28 080, 000 Detailers Average Price per Sale Revenue @ 15% • Cost of Revenue Gross Profit Expenses Total Expenses EBIT 13% Contoso Pharmaceuticals page 17

Team Mirjam Nils Victoria Lindqvist Angelica Astrom COO COB CFO Lorem ipsum dolor sit

Team Mirjam Nils Victoria Lindqvist Angelica Astrom COO COB CFO Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut eleifend. Integer convallis suscipit ante eu varius. Morbi a purus dolor. Suspendisse sit amet ipsum finibus justo viverra blandit. Ut congue quis tortor eget sodales. Nulla a erat eget nunc hendrerit ultrices eu nec nulla. Donec viverra leo aliquet, auctor quam id, convallis orci. Sed in molestie est. Cras ornare turpis at ligula posuere, sit amet accumsan neque lobortis. Contoso Pharmaceuticals page 18

Team Alternate Mirjam Nilsson Victoria Lindqvist Alexander Martensson COO COB CFO Angelica Astrom Mira

Team Alternate Mirjam Nilsson Victoria Lindqvist Alexander Martensson COO COB CFO Angelica Astrom Mira Karlsson Flora Berggren Head of Operations Head of Technical Creative Director Contoso Pharmaceuticals page 19

Funding Fund Category Lorem ipsum dolor sit amet, consectetur adipiscing elit. $14, 000 $32,

Funding Fund Category Lorem ipsum dolor sit amet, consectetur adipiscing elit. $14, 000 $32, 000 Fund Category. Integer convallis suscipit ante eu varius. Morbi a purus dolor. $12, 000 Etiam aliquet eu mi quis lacinia. Ut fermentum a magna ut. $82, 000 Fund Category Suspendisse sit amet ipsum finibus justo viverra blandit. Ut congue quis tortor eget sodales. Contoso Pharmaceuticals page 20

 • Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi

• Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam aliquet eu mi quis lacinia. • Ut fermentum a magna ut eleifend. Integer convallis suscipit ante eu varius. Morbi a purus dolor. Suspendisse sit amet ipsum finibus justo viverra blandit. • Ut congue quis tortor eget sodales. Nulla a erat eget nunc hendrerit ultrices eu. Summary tagline or sub-headline Contoso Pharmaceuticals page 21

Thank You April Hansson +1 23 987 6554 april@contoso. com www. contoso. com Contoso

Thank You April Hansson +1 23 987 6554 april@contoso. com www. contoso. com Contoso Pharmaceuticals page 22

Customize this Template Editing Instructions and Feedback Contoso Pharmaceuticals page 23

Customize this Template Editing Instructions and Feedback Contoso Pharmaceuticals page 23